Stifel Nicolaus Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report) yesterday and set a price target of $32.00. The company’s shares closed yesterday at $27.81.

According to TipRanks, Block is a 4-star analyst with an average return of 6.9% and a 51.01% success rate. Block covers the Healthcare sector, focusing on stocks such as Zoetis, Nyxoah, and Align Tech.

In addition to Stifel Nicolaus, DENTSPLY SIRONA also received a Hold from Piper Sandler’s Jason Bednar in a report issued on May 3. However, on the same day, Barrington maintained a Buy rating on DENTSPLY SIRONA (NASDAQ: XRAY).

The company has a one-year high of $41.11 and a one-year low of $26.04. Currently, DENTSPLY SIRONA has an average volume of 3.5M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

DENTSPLY SIRONA (XRAY) Company Description:

DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.